AI trifecta, VMware moat, and rising capex tailwinds support FCF and dividends. Click to read why AVGO is a Strong Buy.

As new consumer hardware and software capabilities have bumped up against medicine over the last few years, consumers and manufacturers alike have struggled with identifying the line between “wellness ...

As the pace of digital transformation and automation accelerates, the need for a robust and lean risk assessment methodology for software is becoming more and more critical in the life sciences ...